VIP ANTAGONIST,05 MG ,Each

Details:

VIP ANTAGONIST^ 0.5mg This peptide, a hybrid of neurotensin (6-11) and VIP (7-28), is a competitive antagonist of VIP-binding to glial cells. In rats with reduced masculine potential, this molecule markedly inhibits VIP-stimulated sexual behaviour. Furthermore, it has been shown to antagonize VIP receptors on non-small cell lung cancer cells, thereby inhibiting tumor growth in vitro and in vivo. CAS: 125093-93-8 C154H257N49O40S FW: 3467.11 . VIP